Diabetes: Can tight glycemic control in diabetes benefit cognition?

Nature Reviews Neurology

Volumn 8, Issue 3, 2012, Pages 124-126

  Herzog, Raimund I ^a   Sherwin, Robert S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADVERSE OUTCOME; BRAIN SIZE; COGNITION; COGNITIVE DEFECT; DEMENTIA; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MENTAL PERFORMANCE; MICROANGIOPATHY; NEUROIMAGING; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK FACTOR; SHORT SURVEY;

BLOOD GLUCOSE; BRAIN; COGNITION; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE;

EID: 84858150688     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2012.10     Document Type: Short Survey

References (10)

1. Strachan, M. W. R D Lawrence Lecture 2010. The brain as a target organ in type 2 diabetes: exploring the links with cognitive impairment and dementia. Diabet. Med. 28, 141-147 (2011).
2. [No authors listed] The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N. Engl. J. Med. 329, 977-986 (1993).
3. [No authors listed] Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352, 837-853 (1998).
4. Musen, G. et al. The Impact of diabetes and its treatment on cognitive function among adolescents who participated in the DCCT. Diabetes Care 31, 1933-1938 (2008).
5. The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N. Engl. J. Med. 358, 2545-2559 (2008).
6. Launer, L. J. et al. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol. 10, 969-977 (2011).
7. Miller, M. E. et al. The effects of baseline characteristics, glycaemia treatment approach and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. BMJ 340, b5444 (2010).
8. Whitmer, R. A., Karter, A. J., Yaffe, K., Quesenberry, C. P. Jr & Selby, J. V. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 301, 1565-1572 (2009).
9. Herzog, R. I., Sherwin, R. S. & Rothman, D. L. Insulin-induced hypoglycemia and its effect on the brain: unraveling metabolism by in vivo nuclear magnetic resonance. Diabetes 60, 1856-1858 (2011).
10. Murray, A. M. et al. Biomarkers of renal function and cognitive impairment in patients with diabetes. Diabetes Care 34, 1827-1832 (2011).